table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 severe or critically
tocilizumab Mathilde Veiga Karakike ... Andrew Rashad Belhassen-Garc??a MARIPOSA Talaschian Sarhan Biran Hamed Sarhan COVACTA ... Karampitsakos TOCI-RAF Study Group ... Pereira CORIMUNO-TOCI-ICU ... Rojas-Marte CORIMUNO-TOCI-1 ... NCT04377750 ... Somers REMAP-CAP ... Rosas ...

2 studies excluded by filtering options 2

5632 Holt, 2020 2130excludednot a RCTrisk of bias not avaialble
5672 Klopfenstein, 2020 2134excludednot a RCThigh risk of bias

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons